Flavopiridol, an inhibitor of transcription: implications, problems and solutions

Mikhail V Blagosklonny1

  • 1Brander Cancer Research Institute, New York Medical College, New York 10532, USA. m_blagosklonny@nymc.edu

Insights

Flavopiridol, a cyclin-dependent kinase (CDK) inhibitor, shows potential as a transcription inhibitor despite clinical trial setbacks. Its unique mechanism offers new therapeutic possibilities for various conditions.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Flavopiridol, a cyclin-dependent kinase (CDK) inhibitor, initially showed promise but faced challenges in clinical trials.
  • Its complex effects, including protein downregulation, cell cycle arrest, and apoptosis, were not fully understood.

Purpose of the Study:

  • To review the molecular and cellular effects of flavopiridol.
  • To elucidate the mechanisms behind its therapeutic and side effects.
  • To explore novel clinical applications of flavopiridol as a single agent and in combination therapies.

Main Methods:

  • Literature review of flavopiridol's effects on global transcription.
  • Analysis of molecular and cellular mechanisms of action.
  • Evaluation of clinical trial data and preclinical studies.

Main Results:

  • Flavopiridol is a potent inhibitor of global transcription, explaining its diverse cellular effects.
  • Its unique mechanism distinguishes it from other transcription inhibitors like actinomycin D.
  • The drug's pleiotropic effects are linked to its broad impact on gene expression.

Conclusions:

  • Flavopiridol's potent transcription inhibition offers significant clinical potential.
  • Understanding its mechanisms can guide novel therapeutic strategies, including combination treatments.
  • Further research into flavopiridol's unique properties may unlock its full therapeutic value.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...